-
Cambrian Biopharma Raises $60M
Post on 2/9/21
-
Better Choice Announces $2.0 Million Stock Repurchase Program
Post on 2/9/21
-
Comcast to Delay Imposing Nationwide Data Caps
Post on 2/9/21
-
Why Johnson & Johnson's Vaccine Data Is Actually Great News
Post on 2/9/21
-
TYME Closes $100M Registered Direct Offering of Common Stock
Post on 2/8/21
-
Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock
Post on 2/8/21
-
RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stock Split
Post on 2/8/21
-
2021’s Healthiest & Unhealthiest Cities in America – WalletHub Study
Post on 2/8/21
-
SmartBreast Acquires Molecular Breast Imaging Assets from GE Healthcare
Post on 2/8/21
-
Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
Post on 2/8/21
-
Paragon Data Labs Secures Angel Investment
Post on 2/8/21
-
When Will Johnson & Johnson's Coronavirus Vaccine Be Available?
Post on 2/8/21
-
2 Green Flags in Johnson & Johnson's Latest Earnings Report
Post on 2/8/21
-
Johnson & Johnson's Vaccine Is Less Effective Than Rivals. Here's Why It Could Still Win Big
Post on 2/8/21
-
1 Green Flag and 1 Red Flag From Pfizer's Earnings
Post on 2/8/21
-
1 Big Problem in Johnson & Johnson's Latest Earnings Call
Post on 2/8/21
-
Ambu Expands Single-Use Endoscopy Contracts with Two U.S. Group Purchasing Organizations
Post on 2/6/21
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 2/5/21
-
Regeneron Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
Post on 2/5/21
-
Here's How Novavax's Vaccine Stacks Up Against Moderna's and Pfizer's
Post on 2/5/21
-
How Bristol Myers Squibb's Celgene Buyout Continued to Pay Off in Q4
Post on 2/5/21
-
Here's Why Pfizer's a Great Stock to Buy and Hold Now
Post on 2/5/21
-
What's Behind Merck's Disappointing Q4 Results?
Post on 2/5/21
-
Northern Westchester Hospital Opens State-of-the-art Electrophysiology Lab
Post on 2/4/21
-
Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results
Post on 2/4/21
New York
